Celltrion
068270.KS
#838
Rank
S$35.78 B
Marketcap
S$163.55
Share price
0.05%
Change (1 day)
-1.67%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2025 (TTM): S$1.41

According to Celltrion 's latest financial reports the company's current EPS (TTM) is S$1.38. In 2023 the company made an earnings per share (EPS) of S$3.57 a decrease over its 2022 EPS that were of S$3.65.

EPS history for Celltrion from 2007 to 2025

Annual EPS

Year EPS Change
2025 (TTM)S$1.41
2023S$3.57-2.08%
2022S$3.65-11.72%
2021S$4.132.03%
2020S$4.0582.8%
2019S$2.2218.31%
2018S$1.87-36.33%
2017S$2.94161.25%
2016S$1.132.86%
2015S$1.1017.84%
2014S$0.935.87%
2013S$0.88-70.85%
2012S$3.01134.09%
2011S$1.2943.59%
2010S$0.9074.49%
2009S$0.51317.8%
2008S$0.12-71.7%
2007S$0.43